URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Milano

TitleAssociate Professor
InstitutionSchool of Medicine and Dentistry
DepartmentRadiation Oncology
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 647
Rochester NY 14642
 
 Awards And Honors
1988 - 1992Dean's List (all semesters)
1988 - 19921988 to 1992 National Dean's List (all years)
1988 - 1992Honors Program
1988     Notre Dame Scholar
1988     National Honor Society
1991     Alpha Epsilon Delta
1992     Research Scholar
1992     Outstanding Senior Physics Major Award
1992     Phi Beta Kappa  | Epsilon of Indiana Chapter
1993     Academic Commendation
1993     The Dean's Research Fellowship
1996 - 1997Student Travel Awards
1997     Young Investigator Travel Award
1999     George V. Metzger Award
2008     Hero Fund Recognition/Strong Star Certificate of Appreciation (3 awarded)
2008     Rubin-Mitchell Teaching Award
2008     Teacher of the Year Award  | Association of Residents in Radiation Oncology (ARRO)
2009     Simon Kramer New Investigator Award  | Radiation Therapy Oncology Group (RTOG)
2009     Hero Fund Recognition/Strong Star Certificate of Appreciation (8 awarded)
2010     Hero Fund/Strong Star Certificate of Appreciation (2 awarded)
2011     Hero Fund Recognition/Strong Star Certificate of Appreciation (2 awarded)
 
 Selected Publications
List All   |   Timeline
  1. Singh D, Chen Y, Hare MZ, Usuki KY, Zhang H, Lundquist T, Joyce N, Schell MC, Milano MT. Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung. J Thorac Dis. 2014 Apr; 6(4):369-74.
    View in: PubMed
  2. Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB. Reply to g. Gandaglia et Al. J Clin Oncol. 2014 Apr 10; 32(11):1167-9.
    View in: PubMed
  3. Zhang H, Messing EM, Travis LB, Hyrien O, Chen R, Milano MT, Chen Y. Age and Racial Differences among PSA-Detected (AJCC Stage?T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men. Front Oncol. 2013; 3:312.
    View in: PubMed
  4. Shayne M, Culakova E, Milano MT, Dhakal S, Constine LS. The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents. J Cancer Surviv. 2014 Jun; 8(2):167-72.
    View in: PubMed
  5. Chawla S, Schell MC, Milano MT. Stereotactic body radiation for the spine: a review. Am J Clin Oncol. 2013 Dec; 36(6):630-6.
    View in: PubMed
  6. Mangla R, Ginat DT, Kamalian S, Milano MT, Korones DN, Walter KA, Ekholm S. Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes. J Neurooncol. 2014 Jan; 116(2):325-31.
    View in: PubMed
  7. Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol. 2013 Oct 20; 31(30):3807-14.
    View in: PubMed
  8. Maletz K, Moravan M, Milano M. In Regard to Rasmussen et al. Int J Radiat Oncol Biol Phys. 2013 Apr 1; 85(5):1153.
    View in: PubMed
  9. Youn P, Li H, Milano MT, Stovall M, Constine LS, Travis LB. Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: a population-based study. Ann Oncol. 2013 Jan; 24(1):202-8.
    View in: PubMed
  10. Milano MT, Zhang H, Usuki KY, Singh DP, Chen Y. Definitive radiotherapy for stage I nonsmall cell lung cancer: A population-based study of survival. Cancer. 2012 Nov 15; 118(22):5572-9.
    View in: PubMed
  11. Milano MT, Peterson CR, Zhang H, Singh DP, Chen Y. Second primary lung cancer after head and neck squamous cell cancer: Population-based study of risk factors. Head Neck. 2012 Dec; 34(12):1782-8.
    View in: PubMed
  12. Milano MT, Li H, Constine LS, Travis LB. Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients. J Thorac Dis. 2012 Feb; 4(1):22-9.
    View in: PubMed
  13. Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria JR. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol. 2012 May; 51(5):575-83.
    View in: PubMed
  14. Chawla S, Korones DN, Milano MT, Hussain A, Hussien AR, Muhs AG, Mangla M, Silberstein H, Ekholm S, Constine LS. Spurious progression in pediatric brain tumors. J Neurooncol. 2012 May; 107(3):651-7.
    View in: PubMed
  15. Milano MT, Katz AW, Zhang H, Okunieff P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys. 2012 Jul 1; 83(3):878-86.
    View in: PubMed
  16. Katz AW, Chawla S, Qu Z, Kashyap R, Milano MT, Hezel AF. Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation. Int J Radiat Oncol Biol Phys. 2012 Jul 1; 83(3):895-900.
    View in: PubMed
  17. Bredlau AL, Constine LS, Silberstein HJ, Milano MT, Korones DN. Incidental brain lesions in children: to treat or not to treat? J Neurooncol. 2012 Feb; 106(3):589-94.
    View in: PubMed
  18. Milano MT, Zhang H. Second course of radiation for new primary head-and-neck cancer: population-based study of survival. Am J Clin Oncol. 2011 Aug; 34(4):367-71.
    View in: PubMed
  19. Zhang H, Travis LB, Chen R, Hyrien O, Milano MT, Newlands SD, Chen Y. Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients. Cancer. 2012 Mar 1; 118(5):1276-87.
    View in: PubMed
  20. Cheruvu P, Metcalfe SK, Metcalfe J, Chen Y, Okunieff P, Milano MT. Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer. Radiat Oncol. 2011; 6:80.
    View in: PubMed
  21. Milano MT, Li H, Constine LS, Travis LB. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients. Cancer. 2011 Dec 15; 117(24):5538-47.
    View in: PubMed
  22. Milano MT, Singh DP, Zhang H. Thoracic malignant solitary fibrous tumors: A population-based study of survival. J Thorac Dis. 2011 Jun; 3(2):99-104.
    View in: PubMed
  23. Milano MT, Usuki KY, Walter KA, Clark D, Schell MC. Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy: normal tissue dose constraints of the central nervous system. Cancer Treat Rev. 2011 Nov; 37(7):567-78.
    View in: PubMed
  24. Dhakal S, Corbin KS, Milano MT, Philip A, Sahasrabudhe D, Jones C, Constine LS. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys. 2012 Feb 1; 82(2):940-5.
    View in: PubMed
  25. Milano MT, Zhang H. Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol. 2010 Nov; 5(11):1841-8.
    View in: PubMed
  26. Milano MT, Li H, Gail MH, Constine LS, Travis LB. Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. J Clin Oncol. 2010 Dec 1; 28(34):5088-96.
    View in: PubMed
  27. Mangla R, Singh G, Ziegelitz D, Milano MT, Korones DN, Zhong J, Ekholm SE. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. Radiology. 2010 Aug; 256(2):575-84.
    View in: PubMed
  28. Milano MT, Katz AW, Okunieff P. Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ. Am J Clin Oncol. 2010 Apr; 33(2):157-63.
    View in: PubMed
  29. Milano MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN. Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1147-55.
    View in: PubMed
  30. Metcalfe SK, Milano MT, Bylund K, Smudzin T, Rubin P, Chen Y. Split-course palliative radiotherapy for advanced non-small cell lung cancer. J Thorac Oncol. 2010 Feb; 5(2):185-90.
    View in: PubMed
  31. Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA. Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study. J Neurooncol. 2010 May; 98(1):83-92.
    View in: PubMed
  32. Chawla S, Abu-Aita R, Philip A, Lundquist T, Okunieff P, Milano MT. Stereotactic radiosurgery for spinal metastases: case report and review of treatment options. Bone. 2009 Oct; 45(4):817-21.
    View in: PubMed
  33. Milano MT, Chen Y, Katz AW, Philip A, Schell MC, Okunieff P. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Radiother Oncol. 2009 Jun; 91(3):301-6.
    View in: PubMed
  34. Biswas T, Okunieff P, Schell MC, Smudzin T, Pilcher WH, Bakos RS, Vates GE, Walter KA, Wensel A, Korones DN, Milano MT. Stereotactic radiosurgery for glioblastoma: retrospective analysis. Radiat Oncol. 2009; 4:11.
    View in: PubMed
  35. Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, Milano MT. Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys. 2009 Sep 1; 75(1):71-5.
    View in: PubMed
  36. Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol. 2008; 3:36.
    View in: PubMed
  37. Milano MT, Philip A, Okunieff P. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. Int J Radiat Oncol Biol Phys. 2009 Mar 1; 73(3):832-7.
    View in: PubMed
  38. Milano MT, Zhang H, Metcalfe SK, Muhs AG, Okunieff P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat. 2009 Jun; 115(3):601-8.
    View in: PubMed
  39. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72(5):1516-22.
    View in: PubMed
  40. Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, Okunieff P. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer. 2008 Feb 1; 112(3):650-8.
    View in: PubMed
  41. Johnson MD, Sade B, Milano MT, Lee JH, Toms SA. New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol. 2008 Jan; 86(1):109-22.
    View in: PubMed
  42. Milano MT, Constine LS, Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol. 2007 Apr; 17(2):131-40.
    View in: PubMed
  43. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys. 2007 Mar 1; 67(3):793-8.
    View in: PubMed
  44. Milano MT, Garofalo MC, Chmura SJ, Farrey K, Rash C, Heimann R, Jani AB. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol. 2006 Jun; 79(942):497-503.
    View in: PubMed
  45. Kao J, Milano MT, Javaheri A, Garofalo MC, Chmura SJ, Weichselbaum RR, Kron SJ. gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy. Curr Cancer Drug Targets. 2006 May; 6(3):197-205.
    View in: PubMed
  46. Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol. 2006 May; 28(5):1141-51.
    View in: PubMed
  47. Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, Schell MC. Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol. 2006; 45(7):808-17.
    View in: PubMed
  48. Jani AB, Su A, Milano MT. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity. Urology. 2006 Jan; 67(1):147-51.
    View in: PubMed
  49. Kao J, Rosenstein BS, Peters S, Milano MT, Kron SJ. Cellular response to DNA damage. Ann N Y Acad Sci. 2005 Dec; 1066:243-58.
    View in: PubMed
  50. Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao J, Stenson KM, Witt ME, Haraf DJ. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2006 Feb 1; 64(2):382-91.
    View in: PubMed
  51. Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2005 Oct 1; 63(2):354-61.
    View in: PubMed
  52. Milano MT, Vokes EE, Salama JK, Stenson KM, Kao J, Witt ME, Mittal BB, Argiris A, Weichselbaum RR, Haraf DJ. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1096-106.
    View in: PubMed
  53. Salama JK, Haraf DJ, Stenson K, Milano MT, Witt ME, Vokes EE. Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer. Cancer J. 2005 Mar-Apr; 11(2):140-6.
    View in: PubMed
  54. Chmura SJ, Milano MT, Haraf DJ. Reirradiation of recurrent head and neck cancers with curative intent. Semin Oncol. 2004 Dec; 31(6):816-21.
    View in: PubMed
  55. Milano MT, Haraf DJ, Stenson KM, Witt ME, Eng C, Mittal BB, Argiris A, Pelzer H, Kozloff MF, Vokes EE. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck. Clin Cancer Res. 2004 Aug 1; 10(15):4922-32.
    View in: PubMed
  56. Schomas DA, Milano MT, Roeske JC, Mell LK, Mundt AJ. Intensity-modulated radiotherapy and the Internet. Cancer. 2004 Jul 15; 101(2):412-20.
    View in: PubMed
  57. Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP, Kwon OH, Jani AB, Heimann R. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2004 Jun 1; 59(2):445-53.
    View in: PubMed
  58. Kao J, Garofalo MC, Milano MT, Chmura SJ, Citron JR, Haraf DJ. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev. 2003 Feb; 29(1):21-30.
    View in: PubMed
  59. Milano M. Increased risk for dental caries in asthmatic children. Tex Dent J. 1999 Sep; 116(9):35-42.
    View in: PubMed
  60. Milano MT, Bernhard WA. The influence of packing on free radical yields in solid-state DNA: film compared to lyophilized frozen solution. Radiat Res. 1999 Aug; 152(2):196-201.
    View in: PubMed
  61. Milano MT, Bernhard WA. The effect of packing and conformation on free radical yields in films of variably hydrated DNA. Radiat Res. 1999 Jan; 151(1):39-49.
    View in: PubMed
  62. Milano MT, Hu GG, Williams LD, Bernhard WA. Migration of electrons and holes in crystalline d(CGATCG)-anthracycline complexes X-irradiated at 4 K. Radiat Res. 1998 Jul; 150(1):101-14.
    View in: PubMed
  63. Adair SM, Milano M, Lorenzo I, Russell C. Effects of current and former pacifier use on the dentition of 24- to 59-month-old children. Pediatr Dent. 1995 Nov-Dec; 17(7):437-44.
    View in: PubMed
  64. Varade W, Marin E, Milano M, Insel R, Swerdlow S, Williams M. VH gene repertoire of mantle cell lymphomas. Ann N Y Acad Sci. 1995 Sep 29; 764:504-6.
    View in: PubMed

Visualizations


Milano's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department